WORX Share Price | SCWorx Corp. Stock Analysis & Recommendation

Q: Is SCWorx Corp. overvalued or undervalued?

As of 15 May 2017, the valuation grade for SCWorx Corp. moved from does not qualify to risky, indicating a significant deterioration in its financial standing. The company is currently overvalued given its low valuation ratios, including a Price to Book Value of 0.32, EV to Sales of 0.27, and a ROCE of -30.81%. In comparison to peers, SCWorx Corp. has a less favorable EV to EBITDA ratio of -0.55, while Marpai, Inc. shows a worse ratio at -2.4046, and Onfolio Holdings, Inc. has an even more negative EV to EBITDA of -6.4192.The company's stock has underperformed significantly against the S&P 500, with a year-to-date return of -82.16% compared to the index's 12.22%, and a staggering decline of -98.66% over the past five years. This stark contrast in performance further reinforces the view that SCWorx Corp. is overvalued in its current state.

Q: Is SCWorx Corp. technically bullish or bearish?

As of 26 August 2025, the technical trend for SCWorx Corp. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by mixed indicators. The MACD shows mildly bullish signals on both weekly and monthly time frames, while the RSI indicates a bearish monthly signal. Bollinger Bands and moving averages are bearish, and KST is mildly bullish on the weekly but bearish monthly. Dow Theory and OBV show no trend in both weekly and monthly perspectives. In terms of performance, SCWorx has significantly underperformed the S&P 500 across all periods, with a year-to-date return of -82.16% compared to the S&P 500's 12.22%, and a one-year return of -73.32% against the S&P 500's 17.14%.

Q: What does SCWorx Corp. do?

Overview: SCWorx Corp. offers advanced software solutions for the management of healthcare providers' business applications and operates within the Software Products industry, categorized as a micro-cap company.Financial Snapshot: Most recent Net Sales: 1 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 0 Million (Quarterly Results - Mar 2025) Market cap: USD 1.62 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.18 Return on Equity: -29.70% Price to Book: 0.29Contact Details: Address: 590 Madison Ave, NEW YORK NY: 10022-2524 Tel: 1 212 7397825 Fax: 1 302 6555049 Website: https://www.scworx.com/

Q: Should I buy, sell or hold SCWorx Corp.?

Based on the current information regarding SCWorx Corp., it would be advisable to consider a strong sell position. The company is facing significant challenges, including poor management efficiency reflected in a low return on equity (ROE) of 0%, indicating that it is not generating profits effectively. Additionally, SCWorx has reported negative results for the last four consecutive quarters, which raises concerns about its financial health.The operating profit growth rate of 12.64% over the past five years is overshadowed by a recent decline in net profit and negative EBITDA, suggesting ongoing operational difficulties. Furthermore, the substantial drop in net sales and the alarming increase in interest expenses highlight the company's precarious financial situation.Given these factors, including the lack of profitability and negative cash flow, holding or buying shares in SCWorx at this time could pose significant risks. It may be prudent to sell and reassess the situation as the company works to stabilize its operations.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

435

Shareholding (Jun 2026)

FII

0.10%

Held by 3 FIIs

DII

99.90%

Held by 2 DIIs

Promoter

0.00%

Is SCWorx Corp. overvalued or undervalued?

20-Sep-2025

As of May 15, 2017, SCWorx Corp. is considered overvalued and risky due to poor financial ratios and significant underperformance, with a year-to-date return of -82.16% compared to the S&P 500's 12.22%.

View full answer

Is SCWorx Corp. technically bullish or bearish?

20-Sep-2025

As of August 26, 2025, SCWorx Corp. is in a mildly bearish trend with mixed indicators, underperforming the S&P 500 significantly with a year-to-date return of -82.16% compared to the S&P's 12.22%.

View full answer

How big is SCWorx Corp.?

22-Jun-2025

As of Jun 18, SCWorx Corp. has a market capitalization of 1.62 million, with net sales of 2.90 million and a net profit of -1.44 million over the latest four quarters. As of Dec 24, shareholder's funds are 4.49 million and total assets are 6.35 million.

View full answer

What does SCWorx Corp. do?

22-Jun-2025

SCWorx Corp. provides software solutions for healthcare providers' business management and is classified as a micro-cap company with a market cap of $1.62 million. As of March 2025, it reported net sales of $1 million and no net profit.

View full answer

Should I buy, sell or hold SCWorx Corp.?

22-Jun-2025

Compare SCWorx Corp. with Similar Stocks

Taoping, Inc.Onfolio Holdings, Inc.Kubient, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor long term growth as Operating profit has grown by an annual rate 13.42% of over the last 5 years

The company has declared positive results for the last 2 consecutive quarters

Risky -

Majority shareholders : Mutual Funds

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Software Products

Market cap

USD 2 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.11

Return on Equity

-67.36%

Price to Book

0.32

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Jun 2026)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-49.26%

6 Months

-85.55%

1 Year

-92.06%

2 Years

-97.93%

3 Years

-99.4%

4 Years

-99.78%

5 Years

-99.94%

SCWorx Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-11.04%

EBIT Growth (5y)

13.42%

EBIT to Interest (avg)

-2.78

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.18

Sales to Capital Employed (avg)

0.69

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

6.19%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.32

EV to EBIT

-1.10

EV to EBITDA

-1.10

EV to Capital Employed

0.24

EV to Sales

0.45

PEG Ratio

Dividend Yield

ROCE (Latest)

-21.57%

ROE (Latest)

-67.36%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2026

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (2.14%)

Foreign Institutions

Held by 3 Foreign Institutions (0.1%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 0.00% vs -12.50% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 50.00% vs 71.43% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.70",
          "val2": "0.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.10",
          "val2": "-0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.10",
          "val2": "-0.20",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-171.30%",
          "val2": "-182.30%",
          "chgp": "1.10%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -3.33% vs -21.05% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -300.00% vs 72.50% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.90",
          "val2": "3.00",
          "chgp": "-3.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.00",
          "val2": "-1.30",
          "chgp": "23.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "0.10",
          "chgp": "2,900.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.50",
          "val2": "0.20",
          "chgp": "-350.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.40",
          "val2": "-1.10",
          "chgp": "-300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-333.20%",
          "val2": "-421.30%",
          "chgp": "8.81%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

0.70

Operating Profit (PBDIT) excl Other Income

-0.10

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-0.10

-0.20

50.00%

Operating Profit Margin (Excl OI)

-171.30%

-182.30%

1.10%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -12.50% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 50.00% vs 71.43% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

2.90

3.00

-3.33%

Operating Profit (PBDIT) excl Other Income

-1.00

-1.30

23.08%

Interest

3.00

0.10

2,900.00%

Exceptional Items

-0.50

0.20

-350.00%

Consolidate Net Profit

-4.40

-1.10

-300.00%

Operating Profit Margin (Excl OI)

-333.20%

-421.30%

8.81%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -3.33% vs -21.05% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -300.00% vs 72.50% in Dec 2024

All Annual Results

Company CV

About SCWorx Corp.

SCWorx Corp.

Software Products

Scworx Corp, formerly Alliance MMA Inc., offers advanced software solutions for the management of health care providers business applications. Its platform provides data content and services related to the repair, normalization and interoperability of information for healthcare providers and big data analytics. It has developed and markets health information technology solutions and associated services that improve healthcare processes and information flow within hospitals. Its software platform enables healthcare providers to simplify, repair, and organize its data, allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics. Its software modules are engaged in performing various functions, which includes virtualized item master file repair, expansion and automation, contract management, request for proposal automation, rdata integration and warehousing, and charge description master (CDM) management.

Company Coordinates

Company Details

590 Madison Ave , NEW YORK NY : 10022-2524

Tel: 1 212 7397825

https://www.scworx.com/

Registrar Details

Footer loading